Gitte Pedersen

Gitte Pedersen

Auto-generated profile, based on publicly available information

Gitte Pedersen

Department of Infectious Diseases, Aalborg University Hospital, 9000 Aalborg, Denmark

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2010 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
FEFrederik N Engsig
Frederik N Engsig
JGJan Gerstoft
Jan Gerstoft
GKGitte Kronborg
Gitte Kronborg
CLCarsten Schade Larsen
Carsten Schade Larsen
GPGitte Pedersen
Gitte Pedersen
NONiels Obel
Niels Obel
The mortality in patients with persistent low CD4 count despite several years of HAART with sustained viral suppression is poorly documented. We aimed to identify predictors for inadequate CD4 cell recovery and estimate mortality in patients with low CD4 count but otherwise successful HAART.

25 June 2011 in BMC Cancer
Verified
Journal Article
Open access
PDF file
FEFrederik N Engsig
Frederik N Engsig
GKGitte Kronborg
Gitte Kronborg
CLCarsten Schade Larsen
Carsten Schade Larsen
GPGitte Pedersen
Gitte Pedersen
CPCourt Pedersen
Court Pedersen
NONiels Obel
Niels Obel
HIV patients are known to be at increased risk of lung cancer but the risk factors behind this are unclear.

31 May 2017 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MWMaria Wessman
Maria Wessman
KTKristina Thorsteinsson
Kristina Thorsteinsson
JJJørgen Skov Jensen
Jørgen Skov Jensen
MSMerete Storgaard
Merete Storgaard
FRFrederikke F. Rönsholt
Frederikke F. Rönsholt
ALAnne-Mette Lebech
Anne-Mette Lebech
Bacterial vaginosis (BV) has been found to be associated with HIV acquisition and transmission. This is suggested to be due to higher HIV RNA levels in cervicovaginal fluids in women living with HIV (WLWH) with BV, as bacteria associated with BV may induce viral replication and shedding in the genital tract despite undetectable HIV RNA plasma viral load. We examined the prevalence and diagnostic predictors of BV and HIV-1 RNA vaginal shedding in women living with HIV (WLWH) in Denmark, taking into account the presence of human papillomavirus (HPV) and herpes viridae. WLWH between 18–51 years were recruited from six Departments of Infectious Diseases in Denmark during enrolment in the SHADE cohort; a prospective cohort study of WLWH attending regular outpatient care. BV was diagnosed by microscopy of vaginal swabs and PCR was used for detection of BV-associated bacteria, HPV, herpes viridae, and vaginal HIV viral load. Median age of the 150 included women was 41 years; ethnicity was predominantly White (35%) or Black (47%). The majority (96%) was on ART and had undetectable (85%) plasma HIV RNA (<40 copies/mL). BV was diagnosed in 32%. Overall, 11% had detectable vaginal HIV RNA. Both before and after adjustment for BV, age, ethnicity, plasma HIV RNA, CD4 cell count, herpes viridae and HPV, we found no significant predictors of HIV RNA vaginal shedding. In well-treated WLWH, BV, herpes viridae or HPV do not predict vaginal HIV RNA shedding. This implies that HIV shedding does not seem to be increased by BV.

22 March 2011 in APMIS
Verified
Journal Article
Closed access
PDF file
ILInge Kristine Larsen
Inge Kristine Larsen
GPGitte Pedersen
Gitte Pedersen
HSHenrik C. Schønheyder
Henrik C. Schønheyder